F
Fabien Nevo
Researcher at Pasteur Institute
Publications - 8
Citations - 205
Fabien Nevo is an academic researcher from Pasteur Institute. The author has contributed to research in topics: Viral vector & Vaccination. The author has an hindex of 3, co-authored 8 publications receiving 59 citations.
Papers
More filters
Journal ArticleDOI
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.
Min Wen Ku,Maryline Bourgine,Pierre Authié,Jodie Lopez,Kirill Nemirov,Fanny Moncoq,Amandine Noirat,Benjamin Vesin,Fabien Nevo,Catherine Blanc,Philippe Souque,Houda Tabbal,Emeline Simon,David Hardy,Marine Le Dudal,Françoise Guinet,Laurence Fiette,Hugo Mouquet,François Anna,Annette Martin,Nicolas Escriou,Laleh Majlessi,Pierre Charneau +22 more
TL;DR: These results provide evidence of marked prophylactic effects of the LV-based vaccination against SARS-CoV-2 and designate intranasal immunization as a powerful approach against COVID-19.
Journal ArticleDOI
High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris.
François Anna,Sophie Goyard,Ana Ines Lalanne,Fabien Nevo,Marion Gransagne,Philippe Souque,Delphine Louis,Véronique Gillon,Isabelle Turbiez,François-Clément Bidard,François-Clément Bidard,A Gobillion,Alexia Savignoni,Maude Guillot-Delost,François Dejardin,Evelyne Dufour,Stéphane Petres,Odile Richard-Le Goff,Zaineb Choucha,Olivier Helynck,Yves L. Janin,Nicolas Escriou,Pierre Charneau,Franck Perez,Thierry Rose,Olivier Lantz +25 more
TL;DR: Using high‐throughput methods, the serological response against the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) of 1847 participants working in three sites of an institution in Paris conurbation is assessed.
Posted ContentDOI
High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris
François Anna,Sophie Goyard,Ana Ines Lalanne,Fabien Nevo,Marion Gransagne,Philippe Souque,Delphine Louis,Véronique Gillon,Isabelle Turbiez,François-Clément Bidard,François-Clément Bidard,A Gobillion,Alexia Savignoni,Maude Guillot-Delost,François Dejardin,Evelyne Dufour,Stéphane Petres,Odile Richard-Le Goff,Zaineb Choucha,Olivier Helynck,Yves L. Janin,Nicolas Escriou,Pierre Charneau,Franck Perez,Thierry Rose,Olivier Lantz +25 more
TL;DR: The population studied being not particularly exposed to SARS-CoV-2 infection is representative of active workers in the Paris conurbation, suggesting that the current epidemiological models may underestimate the true prevalence of infection.
Journal ArticleDOI
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.
Min-Wen Ku,Pierre Authié,Maryline Bourgine,François Anna,Amandine Noirat,Fanny Moncoq,Benjamin Vesin,Fabien Nevo,Jodie Lopez,Philippe Souque,Catherine Blanc,Ingrid Fert,Sébastien Chardenoux,llta Lafosse,Delphine Cussigh,David Hardy,Kirill Nemirov,Françoise Guinet,Francina Langa Vives,Laleh Majlessi,Pierre Charneau +20 more
TL;DR: In this paper, a transgenic mouse strain expressing the human angiotensin-converting enzyme 2 was generated, and the brain permissiveness to SARS-CoV-2 replication was shown to be high in the lung.
Journal ArticleDOI
Lentiviral vector induces high-quality memory T cells via dendritic cells transduction
Min Wen Ku,Pierre Authié,Fabien Nevo,Philippe Souque,Maryline Bourgine,Marta Romano,Pierre Charneau,Laleh Majlessi +7 more
TL;DR: In this paper, a lentiviral vector harboring the human β2-microglobulin promoter, with predominant expression in immune cells and minimal proximal enhancers to improve vector safety, was reported to efficiently transduces major dendritic cell subsets in vivo.